Structure-activity relationships for thiolytic cleavage rates of antitumor drugs in the 4'-(9-acridinylamino)methanesulfonanilide series.
D000166:Acridines / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D006207:Half-Life; D007700:Kinetics; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D008958:Models, Molecular; D013329:Structure-Activity Relationship; D013424:Sulfanilamides / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use
D000166:Acridines; D000970:Antineoplastic Agents; D013424:Sulfanilamides